510(k) Report

510(k) · Cleared

Cleared

Rnaretain

K113420510(k) TraditionalCleared Mar 16, 2012119-day reviewClass II21 CFR 866.4070

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Asuragen, Inc. · OZF Tissue Rna Preservative For Collection, Storage, And Transportation

Cleared on Mar 16, 2012 as substantially equivalent to DEN050003 (Preanalytix GmbH, 2005) and 1 other predicate after a 119-day review. Its family tree reaches back 2 generations to 2005.

Decided
Mar 16, 2012
Review
119 days
Class
Class II
Product code
OZF
Recalls
None
Predicates
2

Its longest line of descent runs back 2 generations to DEN050003 (2005). No later device cites it as a predicate yet.

  1. Root · 2 generations backDEN050003 Paxgene Blood Rna SystemPreanalytix GmbH · 2005
  2. 1 generation backK082150 Modification to Paxgene Blood Rna SystemPreanalytix GmbH · 2009
  3. This deviceK113420 RnaretainAsuragen, Inc. · 2012
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2DEN050003Paxgene Blood Rna SystemPreanalytix GmbH2005—
−1K082150Modification to Paxgene Blood Rna SystemPreanalytix GmbH2009—
0 (this device)K113420RnaretainAsuragen, Inc.2012—
FIG. 1 — Lineage of K113420, 2005–2012Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in OZF? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*DEN050003Paxgene Blood Rna System
Our reading of the summary gave K042613, which is not in FDA’s 510(k) list. The device the summary names is FDA’s De Novo DEN050003, Paxgene Blood Rna System (Preanalytix GmbH), granted Apr 18, 2005; older De Novo requests were first filed under a 510(k) number, so this links to the grant.
Preanalytix GmbH2005—
*K082150Modification to Paxgene Blood Rna System
Summary page 4
…est Article Predicate Name RNARetaino PAXgene" Blood RNA System 510(k) k113420 k082150; k042613 number 510(k) holder Asuragen, Inc. PreAnalytiX GMBH Austin, TX…
Preanalytix GmbH2009—
†K070675MammaprintAgendia BV20071

Also cleared against DEN050003: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 7 years and passes through 2 companies; a new generation was cleared every 3.8 years on median.
  • None of the 2 ancestors has a recall.
  • 1 other device also cites its predicate DEN050003.

How does its category compare?

All OZF devices

OZF Tissue Rna Preservative For Collection, Storage, And Transportation: FDA decisions, review times, recalls and adverse event reports over 20 years. 2012, this device’s year, is highlighted.

FDA decisions per year · OZF

1in 2012

2012: 1
2007high 1 (2012) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · OZF

Too few OZF 510(k)s in any year since 2007 to give a median.

Recalls per year · OZF

No recall names OZF since 2007.

Adverse event reports per year · OZF

No MAUDE report names OZF since 2007.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20121—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
20200—00
20210—00
20220—00
20230—00
20240—00
20250—00
20260—0—

What is it indicated for?

The RNARetain® device is a single-use, prefilled container intended for the collection,

storage, and transportation of fresh breast tissue specimens for subsequent RNA

isolation and further molecular diagnostic testing.

For Professional Use Only.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K113420: Rnaretain.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K113420

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026